Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-18-000030

Chief Commercial Officer sold 3,750 shares at $3.47 ($13,023)

  • Chief Commercial Officer acquired 9,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bass Gregory Brooks Chief Commercial Officer 2017-12-29 Option exercise +9,375 9,375 D
Bass Gregory Brooks Chief Commercial Officer 2017-12-29 Sale −3,750 $3.47 $13,023 5,625 D
Derivatives
Bass Gregory Brooks Chief Commercial Officer 2017-12-29 Option exercise · Restricted Stock Unit −9,375 28,125 D
Open-market sales · 3,750 sh · avg $3.47 · $13,023
Loading xslF345X03/doc4_5170.xml…